Argon supper-cryosurgery for patients with middle and late stage liver cancer.
OBJECTIVE
To assess the value of argon supper-cryosurgery for 42 patients with middle and late stage liver cancer.


METHODS
Forty-two patients who had received argon supper-cryosurgery were analyzed retrospectively in terms of their clinical characteristics as well as the performance of argon supper-cryosurgery.


RESULTS
All patients were ameliorated in symptoms shortly after the operation, including pain alleviation, psyche straightening up, alpha-fetoprotein descending or recovery. Jaundice occurred in 1 patient and intraabdominal hemorrhage in 2. The levels of aspartate transaminase and alanine transaminase in all patients were elevated 1 month after the operation, and normalized after protective therapy of the liver. No operative death was noted.


CONCLUSIONS
Cold and heat reversed therapy of argon supper-cryosurgery can drastically destroy tumor tissue, especially the tumors which are too large to resect or close to the large vessels. It is applicable to increase the operative rate, decrease the operative death rate, and enlarge the therapeutic scope.
Dou
Ke-Feng
KF
Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. doukf@fmmu.edu.cn
Yue
Shu-Qiang
SQ
Li
Hai-Ming
HM
Yang
Yan-Ling
YL
Tao
Kai-Shan
KS
Guan
Wen-Xian
WX
Chen
Yong
Y
Sun
Kai
K
D000328:Adult; D000368:Aged; D001128:Argon; D003452:Cryosurgery / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies; D016896:Treatment Outcome
D001128:Argon